Skip to main content
IRLAB Therapeutics logo

IRLAB Therapeutics — Investor Relations & Filings

Ticker · IRLAB ISIN · SE0012675361 LEI · 549300JAT34LHEI0DH60 ST Manufacturing
Open in API
Filings indexed 156 across all filing types
Latest filing 2025-10-09 Board/Management Inform…
Country SE Sweden
Listing ST IRLAB

About IRLAB Therapeutics

https://irlab.se/

IRLAB Therapeutics is a research and development company that discovers and develops novel treatments for neurodegenerative diseases, with a primary focus on Parkinson's disease and other central nervous system (CNS) disorders. The company's research originates from Nobel Prize-winning science and is driven by its proprietary Integrative Screening Process (ISP) platform. This systems pharmacology-based discovery engine utilizes an extensive database to generate a pipeline of drug candidates. The company's portfolio includes clinical-stage assets such as Mesdopetam (IRL790), in development for treating levodopa-induced dyskinesia (LIDs), and Pirepemat (IRL752), which is being developed to reduce falls and improve balance in patients with Parkinson's disease.

Recent filings

Filing Released Lang Actions
IRLAB appoints Gustaf Albèrt as the new Chief Financial Officer.
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new Chief Financial Officer (CFO) at IRLAB Therapeutics AB. This falls under the category of management changes, which is explicitly defined as 'Board/Management Information' (MANG).
2025-10-09 English
Ändring av antalet aktier och röster i IRLAB Therapeutics AB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release announcing a change in the total number of shares and votes in IRLAB Therapeutics AB following a rights issue. This type of disclosure is a standard regulatory requirement for listed companies regarding capital structure changes. While it mentions a 'Bifogade filer' (attached files) section, the text itself provides the core information regarding the share count change. According to the filing definitions, an announcement regarding new share issues or capital changes is classified as 'SHA'.
2025-08-29 Swedish
Change in number of shares and votes in IRLAB Therapeutics AB
Share Issue/Capital Change Classification · 100% confidence The document announces a change in the total number of shares and votes in IRLAB Therapeutics AB following a rights issue. This type of disclosure regarding capital structure changes, specifically the increase in share count, falls under the category of share issues and capital changes.
2025-08-29 English
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport januari – juni 2025' (Interim Report January – June 2025) for IRLAB Therapeutics. It contains comprehensive financial tables (income statement, cash flow, etc.) for the period, a CEO statement, and detailed updates on clinical trials and research progress. It is a full interim financial report, not an announcement of a report or a simple earnings release. H1 2025
2025-08-27 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report January – June 2025' and contains detailed financial tables (Net sales, Operating profit, Earnings per share, etc.) for the specified period, along with management commentary, R&D updates, and a financial summary. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-27 English
IRLAB appoints Roy Jonebrant as interim CFO
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new interim CFO at IRLAB Therapeutics AB. This falls under the category of management changes, which is explicitly defined as 'Board/Management Information' (MANG).
2025-08-21 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.